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Abstract 
Background 
The majority of pancreases, offered in allocation, are not transplanted. This pancreas under-
utilisation is a phenomenon observed in all transplant systems in North-America and Europe. 
It was the aim of this study to analyse factors predictive of pancreas non-transplantation in 
Germany. 
Methods 
Routine Eurotransplant data of 3,666 deceased German donors (from 2002–2011) were used 
for multivariate modelling. Socio-demographic and medical factors were considered as 
independent variables in logistic regression models with non-transplantation as dependent 
variable. 
Results 
Male gender, advanced age, overweight/obesity, long ICU stay, a history of smoking, non-
traumatic brain death, elevated levels of sodium, serum glucose, lipase/amylase and the liver 
not being considered for procurement were significant independent predictors of non-
transplantation. 
Conclusion 
In line with previous research, advanced age, high BMI, long ICU stay and the liver not being 
considered for procurement were the strongest predictors of pancreas non-transplantation in 
Germany. About three quarters of the variance remained unexplained, suggesting that factors 
not assessed or unknown may play a decisive role. 
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Background 
Pancreas or islet transplantation is currently the only means to restore normal glucose 
metabolism and substantially improves quality of life in patients with type 1 diabetes [1,2]. In 
patients with diabetes mellitus and end-stage renal disease, simultaneous pancreas-kidney 
transplantation is associated with decreased mortality compared with patients on the waiting 
list or deceased kidney-only transplant recipients [3-6]. Not all patients eligible for pancreas 
transplantation benefit from this therapeutic option which is commonly linked to a shortage 
of donor organs. Less emphasis has been put on the fact that not all donor pancreases offered 
for allocation are appropriately used. Pancreas underutilization has been reported for the 
United States [7] and the Eurotransplant (ET) region [8]. 
Using routine data from ET we have previously analysed physician-reported refusal reasons 
to better understand why offered pancreases are refused in the allocation process [9]. A 
multitude of refusal reasons has been reported which were grouped in four domains: donor-
related criteria, recipient-related criteria, logistic criteria and technical criteria. Overall, the 
significance of various refusal reasons was not judged in a consistent manner and often, 
refusal reasons seemed to lack plausibility in the absence of evidence supporting the refusal. 
Some donor characteristics were quite unambiguous reasons for discarding a pancreas. For 
example, among pancreases for which ‘diabetes mellitus in the donor’, ‘malignancy in the 
donor’ or ‘CIT’ were named at least once, the proportion of finally transplanted organs was 
below 10% (4, 7, and 8%, respectively). Other criteria were obviously less distinct: for 
instance, organs refused at least once for ‘trauma in donor’, ‘donor age’, or ‘resuscitation’ 
were later transplanted in 48%, 32%, and 28% of cases, respectively. 
In light of these findings, it is of interest to understand which objective donor-related factors 
are predictive of non-transplantation. 
Therefore, the aim of this study was to investigate the relative importance of relevant socio-
demographic and medical donor characteristics in determining non using a large sample from 
the ET-area for 2002–2011. 
Methods 
Data source 
The analysis is based on the database in which ET routinely collects medical and socio-
demographic information on deceased potential organ donors during the allocation procedure. 
A detailed description of the sampling frame is given elsewhere [9]. 
Briefly, the study population is composed of all German pancreas donors reported between 
Jan 1st 2002 and Dec 31st 2011, whose organs were offered for allocation. According to 
previous studies we included all donors older than 10 years as they could be classified as 
'adult' donors [10-13]. We excluded those donors where pancreatic islet cell transplantation 
was intended or performed in the end. We also excluded all donors with a positive test for 
Human Immunodeficiency Virus (HIV), since an HIV infection represents a general 
contraindication for pancreas donation. 3,666 donors aged 11–69 years were included. 
Predictive variables 
The following variables pertaining to the social and medical history of the donors as well as 
technical and logistic information were included for analysis: 
• donor gender [male/female] 
• 
body mass index (BMI) [kg/m2], based on weight/height2 and formed categories for <19, 
20–24, 25–29 and ≥30 
• 
age, at the time of brain death, categorized in 7 age groups for 11–19, 20–29, 30–39, 40–
44, 45–49, 50–54 and ≥55 years 
• 
duration of the ICU stay (based on date of registration minus date of admission to the 
ICU), categorized as 0–2, 3–7, 8–11, 12–15 and ≥16 days; values >32 days were 
considered implausible and therefore classified as missing 
• 
serum level of amylase [U/l], categorized as low (<130), elevated (130–389) and highly 
elevated (≥390) 
• 
serum level of lipase [U/l], categorized as low (<160), elevated (160–479) and highly 
elevated (≥480) 
• 
serum level of lipase/amylase [U/l], categorized as low, elevated and highly elevated 
where; categories for lipase were used if available and supplemented by categories for 
amylase if lipase values were not available 
• 
serum level of sodium [mmol/l], categorized as <120, 120–134, 135–145, 146–159 and 
≥160 
• 
serum level of blood glucose [mg/dl], categorized as <100, 100–130, 131–180, 181–209 
and ≥210; values lower than 50 and higher than 300 were considered implausible and 
therefore classified as missing 
• 
glycated hemoglobin (HbA1c) in % of total haemoglobin; values >40 were considered 
implausible and therefore classified as missing 
• cause of death [traumatic/non-traumatic], based on the documented ICD-10 diagnosis 
• catecholamine administration [yes/no], based on the use of dopamine/γ or adrenalin/γ 
• virology statement [yes/no], if any of CMV, HBV or HCV was positive 
• history of smoking [yes/no] based on medical history by proxy 
• donor region [region 1–7 in Germany] 
• year of registration [2002–2011] 
• 
information on the liver, if it was considered for allocation as an indicator for the 
possibility to procure abdominal organs [yes/no] [11,14,15]. 
The factors were selected based on a review of the literature and previous findings on 
differences between donors of transplanted and non-transplanted pancreases [9,16]. 
Outcome variable 
Outcome was defined as non-transplantation of the pancreas. 
Missing values 
There were no missing values for donor region, donor gender, donor weight/height, date of 
birth, date/time of brain death. In 203 cases the date/time of admission to ICU was not 
available, or the computed length of ICU stay was negative or beyond 31 days. These values 
were classified as ‘missing’. 
Data management and statistical analysis 
Using Microsoft Excel, a database was compiled which included donors’ socio-demographic 
and medical information. Statistical analyses were undertaken using SAS version 9.0 WIN 
(Cary NC, USA). Median and range were computed for continuous variables due to evidence 
for non-normality of the considered variables. Counts and per cent were computed for 
categorical variables. Donor factors were compared between donors whose pancreas was 
discarded and donors whose pancreas was transplanted, using Pearson’s Chi-square-test. 
Since donor age, length of ICU stay and the considered lab values were not normally 
distributed, differences in these continuous variables were tested using the non-parametric 
Mann–Whitney-U-Test. A p-value below 0.05 was considered statistically significant. 
Univariate logistic regression was used to explore the relationship between each of the 
explanatory variables described above and pancreas non-transplantation. Multivariate logistic 
regression was then used to explore the independent effects of the explanatory variables. We 
obtained crude and adjusted odds ratios (ORs) and 95% confidence intervals (CIs). For our 
full model we included all continuous and categorical items listed above. Stratified analyses 
were performed for donor gender. In order to arrive at parsimonious models we performed 
backward selection (p-value for exclusion: 0.1). All analyses are adjusted for donor region 
and year of donation. 
Ethical approval 
As no personal data for identification of (potential) pancreas donors were visible, no 
authorized approval was needed as per the ethics committee of the University of Regensburg 
(reference number 11-160-0192). 
Results 
Of the 3,666 evaluated donor organs 2,232 (60.9%) were discarded. Of the utilized 
pancreases, 1,268 (88.4%) were transplanted together with a kidney (simultaneous pancreas 
kidney transplantation, SPK), 135 (9.4%) as pancreas transplantation alone (PTA) or 
pancreas after kidney transplantation (PAK) and 31 (2.2%) in combination with heart, liver or 
intestine as “approved combined organ” (ACO) transplantation. 
Characteristics of the study population 
Socio-demographic and medical characteristics of all donors are shown in Table 1. The 
median age of all donors was 40 years and there were more males in the sample than females. 
Median BMI was 24.1 kg/m2 and median duration of ICU stay was 3.2 days. For more than 
40% of all donors a history of smoking. Slightly more than half of all donors had a positive 
virology statement (Hepatitis B or C or Human Cytomegalovirus) and around 39.6% had a 
traumatic cause of brain death. Catecholamine was administered in around 78.4%. The 
pancreas was procured in 54.8%. 
Table 1 Donor characteristics of all donors 
 All donors (n = 3,666) N 
Age (mean, years) 36.97 3666 
Age (median, years) 40.08  
Age (range, years) 11-69  
Donors 11 < years < 20 (%) 11.35  
Donors >45 years (%) 30.58  
Positive virology statement (%) 53.80 3656 
Male (%) 56.11 3666 
Traumatic Cause of brain death (%) 39.61 3663 
BMI (mean, kg/m2) 24.11  
BMI (median, kg/m2) 24.07  
BMI (range, kg/m2) 11-42  
Liver NOT reported (%) 0.74 3666 
P-PASS (median) 17.58 3408 
P-PASS (range) 9-25  
ICU stay (mean, days) 4.87 3463 
ICU stay (median, days) 3.19  
ICU stay (range, days) 0-31  
ICU stay >7 days (%) 19.90  
History of smoking 43.25 3082 
Catecholamine administration (%) 78.40 3666 
 All donors (n = 3,666) N 
Pancreas procured (%) 54.75 3666 
Sodium (mean, mmol/L) 147.08 3663 
Sodium (median, mmol/L) 147.00  
Sodium (range, mmol/L) 6-193  
Lipase (mean, U/l) 770.34 3020 
Lipase (median, U/l) 35.00  
Lipase (range, U/l) 0-45383  
Amylase (mean, U/l) 530.20 2899 
Amylase (median, U/l) 86.00  
Amylase (range, U/l) 0-47119  
Serum glucose (mean, mg/dl) 140.21 3243 
Serum glucose (median, mgl/dl) 131.00  
Serum glucose (range, mg/dl) 50-300  
HbA1c (mean,%) 5.46 577 
HbA1c (median,%) 5.40  
HbA1c (range,%) 0.01-37.00  
BMI: Body Mass Index, ICU: Intensive Care Unit, U/L: Units Per Litre. 
Analysis of donor factors - univariate associations 
The comparison of the above mentioned characteristics between those whose pancreas was 
discarded and those whose pancreas was transplanted is shown in Table 2. Median age, 
median BMI, median duration of ICU stay as well as median serum levels of sodium, 
glucose, lipase and amylase were significantly higher in those whose pancreas was discarded 
compared to those whose pancreas was transplanted. The prevalences of male gender, a 
history of smoking and a positive virology statement were significantly higher in those whose 
pancreas was discarded compared to those whose pancreas was transplanted. Donors whose 
organs were not transplanted deceased significantly more often from cerebro-vascular brain 
death than primarily traumatic brain death. 
Table 2 Comparison of donor characteristics 
 Pancreases discarded 
(n = 2,232) 
Pancreases transplanted 
(n = 1,434) 
P N 
Age (mean, years) 39.63 32.82  3666 
Age (median, years) 42.61 33.68 <0.0001  
Age (range, years) 11-69 11-58   
Donors 11 < years < 20 (%) 7.17 17.85   
Donors >45 years (%) 38.22 18.69   
Positive virology statement (%) 55.66 50.91 0.005 3656 
Male (%) 57.53 53.91 0.0311 3666 
Traumatic Cause of brain death (%) 34.59 47.42 <0.0001 3663 
BMI (mean, kg/m2) 24.58 23.36   
BMI (median, kg/m2) 24.49 23.24 <0.0001  
BMI (range, kg/m2) 12-42 11-35   
Liver NOT reported (%) 1.03 0.28 0.0094 3666 
P-PASS (median) 19.00 17.00 <0.0001 3408 
P-PASS (range) 10-25 9-24   
ICU stay (mean, days) 5.62 3.69  3463 
ICU stay (median, days) 3.94 2,58 <0.0001  
ICU stay (range, days) 0-31 0-31   
ICU stay >7 days (%) 25.84 10.64 <0.0001  
History of smoking 47.62 36.71 <0.0001 3082 
Catecholamine administration (%) 78.76 77.82 0.5002 3666 
Pancreas procured (%)    3666 
Sodium (mean, mmol/L) 147.57 146.30  3663 
Sodium (median, mmol/L) 147.00 146.00 <0.0001  
Sodium (range, mmol/L) 6-193 60-189   
Lipase (mean, U/l) 733.30 828.34  3020 
Lipase (median, U/l) 40.00 29.00 <0.0001  
Lipase (range, U/l) 0-45383 0-42767   
Amylase (mean, U/l) 585.49 444.03  2899 
Amylase (median, U/l) 92.00 82.00 0.0008  
Amylase (range, U/l) 0-44287 6-47119   
Serum Glucose (mean, mg/dl) 142.11 137.25  3243 
Serum Glucose (median, mg/dl) 133.33 127.00 0.0078  
Serum Glucose (range, mg/dl) 50.00-300.00 54.05-294.00   
HbA1c (mean,%) 5.52 5.35  577 
HbA1c (median,%) 5.40 5.40 0.1453  
HbA1c (range,%) 0.01-37.00 2.50-6.70   
Analysis of donor factors – multivariate associations 
In multivariate analysis (see Table 3), male gender, history of smoking, a primarily non-
traumatic cause of brain death (e.g. stroke), a longer ICU stay and liver not being considered 
for donation or procurement showed significant positive associations with non-
transplantation. The chance of a pancreas not being transplanted increased for each age group 
from 30–39 years up to the group 55 years and older and also increased with weight for 
height (BMI) category. High levels of sodium and blood glucose were significantly 
associated with non-transplantation as well as elevated or highly elevated levels of either 
lipase or amylase. Catecholamine administration was not significantly related to non-
transplantation. 26% of the variance was explained by the variables considered. 
Table 3 Adjusted full model 
Variables description Full model 
−2LL: 2774, adj. r2: 0.26 N 
   2441 
OR 95%-CI  
gender male vs female 1.57 1.29 1.91  
age 11-19 vs 20–29 yrs 1.06 0.75 1.49  
 30-39 vs 20–29 yrs 1.80 1.35 2.40  
 40-44 vs 20–29 yrs 2.64 1.96 3.56  
 45-49 vs 20–29 yrs 3.49 2.59 4.71  
 50-54 vs 20–29 yrs 4.53 2.84 7.23  
 55 and older vs 20–29 yrs 91.61 12.12 692.24  
BMI 0-19 vs 20-24 1.12 0.75 1.66  
 25-29 vs 20-24 1.98 1.60 2.44  
 30 and more vs 20-24 3.13 1.32 7.39  
ICU stay 3-7 vs 0–2 days 1.48 1.21 1.82  
 8-11 vs 0–2 days 2.69 1.96 3.69  
 12-15 vs 0–2 days 4.96 2.94 8.37  
 16 and longer vs 0–2 days 4.85 2.41 9.78  
History of smoking Smoking Yes vs No 1.32 1.10 1.60  
Cause of brain death traumatic brain death No vs Yes 1.28 1.04 1.58  
Sodium Sodium <120 vs 135-145 2.17 0.26 23.97  
 Sodium 120–134 vs 135-145 0.97 0.66 1.42  
 Sodium 146–159 vs 135-145 1.14 0.94 1.39  
 Sodium 160 < vs 135-145 1.75 1.18 2.61  
Serum blood glucose Glucose <100 vs 100-130 1.23 0.93 1.62  
 Glucose 131–180 vs 100-130 1.18 0.95 1.47  
 Glucose 181–209 vs 100-130 0.90 0.61 1.31  
 Glucose 210 < vs 100-130 1.76 1.21 2.58  
Lipase/Amylase if at least one value was given**     
 elevated vs low 1.39 1.03 1.87  
 highly elevated vs low 2.06 1.27 3.33  
Virology min. 1 positive virol. Statement removed / backward-selection 
Catecholamine administration Yes vs No removed / backward-selection 
Status of Liver Liver not reported vs liver reported 4.95 1.01 24.13  
**Amylase categorized as low (<130), elevated (130–389) and highly elevated (≥390); Lipase categorized as low (<160), 
elevated (160–479) and highly elevated (≥480); the categories were chosen if either one of the enzymes scored 
elevated/highly elevated. 
Subgroup analyses 
In gender-stratified analyses (see Table 4), both overweight and obesity as well as prolonged 
ICU stay showed stronger associations with non-transplantation in female donors than in 
male donors. No substantial differences in effect estimates were observed for age group and 
lipase/amylase although the significant associations with lipase/amylase were only found for 
highly elevated values. History of smoking was only significantly related to non-
transplantation in male donors. The remainder of the considered variables could not be 
compared due to variables being removed in either one or both models: cause of brain death 
and serum sodium level were removed for the model encompassing females and serum blood 
glucose for the model including males after backward selection. Virology statement, 
catecholamine administration and the status of the liver were removed in both groups. 
Table 4 Adjusted full models according to gender 
Variables description Adjusted / stratified by gender 
  female donors male donors 
  −2LL: 1475, adj. r2: 0.24 N −2LL: 1493, adj. r2: 0.28 N 
   1081  1360 
  OR 95%-CI  OR 95%-CI  
age 11-19 vs 20–29 yrs 1.40 0.76 2.58  0.94 0.62 1.42  
 30-39 vs 20–29 yrs 1.46 0.90 2.36  2.16 1.50 3.11  
 40-44 vs 20–29 yrs 2.00 1.24 3.24  3.60 2.41 5.38  
 45-49 vs 20–29 yrs 2.64 1.66 4.21  4.67 3.07 7.09  
 50-54 vs 20–29 yrs 5.06 2.55 10.06  3.90 2.02 7.52  
 55 and older vs 20–29 yrs 54.12 6.66 439.73  N/A  
BMI 0-19 vs 20-24 1.03 0.63 1.68  1.40 0.71 2.76  
 25-29 vs 20-24 2.52 1.81 3.52  1.66 1.26 2.20  
 30 and more vs 20-24 4.00 1.30 12.30  2.56 0.65 10.02  
ICU stay 3-7 vs 0–2 days 1.65 1.21 2.24  1.40 1.07 1.84  
 8-11 vs 0–2 days 2.46 1.58 3.84  3.26 2.06 5.15  
 12-15 vs 0–2 days 6.34 3.25 12.38  4.18 1.77 9.87  
 16 and longer vs 0–2 days 6.57 2.54 16.98  3.77 1.29 11.07  
History of smoking Smoking Yes vs No 1.31 0.98 1.74  1.37 1.06 1.77  
Cause of brain death traumatic brain death No vs Yes removed / backward-selection 1.42 1.09 1.85  
Sodium Sodium <120 vs 135-145 removed / backward-selection N/A  
 Sodium 120–134 vs 135-145     0.64 0.37 1.10  
 Sodium 146–159 vs 135-145     1.18 0.90 1.54  
 Sodium 160 < vs 135-145     1.71 1.02 2.86  
Serum blood glucose Glucose <100 vs 100-130 1.43 0.93 2.18  removed / backward-selection 
 Glucose 131–180 vs 100-130 1.28 0.92 1.76      
 Glucose 181–209 vs 100-130 0.99 0.58 1.67      
 Glucose 210 < vs 100-130 2.71 1.54 4.74      
Lipase/Amylase if at least one value was given**         
 elevated vs low 1.18 0.74 1.87  1.47 0.99 2.21  
 highly elevated vs low 2.20 1.07 4.50  2.06 1.09 3.91  
Virology min. 1 positive virol. Statement removed / backward-selection removed / backward-selection 
Catecholamine administration Yes vs No removed / backward-selection removed / backward-selection 
Status of Liver Liver not reported vs liver reported removed / backward-selection removed / backward-selection 
24% of the variance was explained in the model for females while 28% of the variance was 
explained in the model for male donors. 
Discussion 
Principal findings 
In our analysis we identified several donor factors which were significantly associated with 
non-transplantation: increasing age, increasing ICU stay, overweight/obesity, liver not 
reported for procurement, history of smoking, male gender, a primarily non-traumatic cause 
of brain death and high levels of sodium, blood glucose, amylase and lipase. The focus of the 
study was the investigation of factors that were independently associated with non-
transplantation and not the analysis of medical and non-medical reasons for organ refusal 
which have been previously reported [17]. 
The factors which showed the strongest association with non-transplantation of a donor 
pancreas were non-availability of the liver for procurement, prolonged ICU treatment, obesity 
and donor age >50 years. The high estimate linked to liver procurement might arise from the 
fact that the donors suffering from a severe abdominal trauma are generally not accepted for 
pancreas transplantation. In addition, liver not being reported for transplantation may indicate 
a poor general condition of the donor which may in turn account for the pancreas not being 
transplanted, too. 
We also found effect modification by gender for BMI and duration of ICU stay. In both cases 
effect estimates were substantially stronger in female compared to male donors. 
Strengths and weaknesses of the study 
Strengths of the study include the selection of a broad spectrum of variables as influencing 
factors, the use of multivariate regression modelling to assess independent effects and the 
large sample size. Differences over the years and between regions are accounted for as all 
multivariate models were adjusted for donor region and year of donation. To our knowledge, 
this is the largest study conducted so far comparing donors whose pancreas was discarded 
and donors whose pancreas was transplanted. Since Germany contributes ≈ 60% of all 
donated organs in ET [8,18], our findings are also relevant for the ET-area as a whole. 
It must be acknowledged that we used routine data, so missing and implausible data could not 
be avoided in some cases which resulted in a slightly reduced sample. We did not look at 
long-term outcome of graft or patient survival because these data were not available when our 
analyses were carried out. 
Comparison to other studies 
Other groups have previously performed similar comparisons, but only one study undertook 
analyses that are directly comparable to ours. In this study, data from consecutively reported 
pancreas donors for the period January 2002 to June 2005 were used to establish a prognostic 
score for the acceptance of a pancreas, the pre-procurement pancreas suitability score (P-
PASS) [19]. 1,190 accepted pancreata were compared with 985 refused organs. In line with 
our findings, donors of pancreata that were not accepted were older, had fewer traumatic 
brain deaths, stayed on ICU for a longer period and had higher median values for sodium, 
amylase and lipase. In contrast to our study, Vinkers et al. did not find a difference in median 
BMI. They also reported that the gender distribution between groups was almost identical 
whereas we discovered the proportion of males to be significantly higher in those whose 
pancreas was discarded. As expected, median P-PASS was significantly higher in discarded 
pancreata compared to transplanted pancreata in our study but our values were higher 
compared to the P-PASS validation study (19.00/17.00 in our study vs 16.50/14.50). 
Wullstein et al. compared accepted pancreas grafts and pancreas grafts refused for medical 
reasons, using all offered pancreata in the ET area between May 2002 and September 2003 
[20]. As could be expected, significant differences were found for age, BMI, a history of 
smoking, serum glucose, amylase and lipase in the same direction as was shown by our 
analyses. However, their samples were older compared to our sample but a history of 
smoking was more frequently reported in our samples. In contrast to our findings, Wullstein 
et al. found the occurrence of a traumatic cause of brain death to be higher in those pancreas 
grafts that were refused for medical reasons. The comparison with the study by Wullstein et 
al. is hampered by the fact that we did not exclude organs that were refused for other than 
medical reasons. 
Wiseman et al. examined Organ Procurement and Transplantation Network (OPTN) data 
from the US between 2005 and 2007 and compared 4,163 pancreas donors with 1,763 
“potential pancreas donors” (PPD, defined by age 19–40 years, BMI < 30 kg/m2, successful 
liver donation and negative viral serology testing who would typically result in organ 
acceptance but had not been accepted [15]. In accordance with our findings, a higher age, a 
higher proportion of head trauma and higher values for lipase and amylase were found in 
PPD compared to actual pancreas donors. Similarly to Vinkers et al. [19], and contrasting our 
findings, no significant difference was found for BMI. It is evident that a direct comparison 
with the study performed by Wiseman et al. is hampered by the fact that PPD is a subsample 
of all declined pancreata which we had fully considered in our analyses. 
None of the papers considered for comparative purposes have included ICU stay in their 
analyses which in our analysis emerged as one of the factors that was strongly related to the 
outcome of non-transplantation. Hence we went further than previous studies. However, 
when considering the variance explained in our full model it becomes apparent that 74% of 
the variance remain to be explained. This suggests that yet unknown factors may play an 
influential role. Therefore, any attempt to establish clear criteria for organ quality based on 
comparisons between declined and accepted pancreata needs to be viewed with caution. We 
seem to lack knowledge on further factors that are important and powerful predictors. In this 
context, Wiseman et al. [15] refer to the severity of factors (such as smoking) which may play 
an important role but are not captured in the available data. He also points out that the 
available data in general do not well reflect the criteria that are in fact taken into account 
when accepting or rejecting an organ. 
Conclusion 
Using routine ET data for German pancreas donors from 2002 to 2011, we present current 
data on factors determining pancreas non-transplantation and provide the most 
comprehensive analysis on this matter so far. We expand existing knowledge and have shown 
that in addition to advanced age and high BMI a long ICU stay and the liver not being 
considered for procurement were the strongest predictors of pancreas non-transplantation in 
Germany. The effects of BMI and ICU stay appear to be substantially stronger in females. 
The results are relevant for the ET region as a whole. About three quarters of the variance in 
multivariate analysis remained unexplained, suggesting that factors not assessed or unknown 
may play a decisive role. 
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